Patent Prognosis: Pfizer’s Chief IP Counsel On The Year Ahead

 
• By William Looney
  
Waldron_RoyF_1200x675
Roy Waldron, PhD, Pfizer SVP & Chief IP Counsel

More from Innovation

More from In Vivo